Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort

• Egile Nagusiak: Stine Elsgaard, MBBS (Egilea), Anna Kathrine Danielsen, MBBS (Egilea), Jacob P. Thyssen, MD, PhD, DMSc (Egilea), Mette Deleuran, MD, DMSc (Egilea), Christian Vestergaard, MD, PhD, DMSc (Egilea)
• Formatua: Liburua
• Argitaratua: Wolters Kluwer, 2021-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: : Systemic immunosuppressive treatments are central in the treatment of severe atopic dermatitis (AD). Yet, comparative data are sparse on the performance of such immunosuppressive treatments in pediatric cohorts with severe AD. Objective: : This study aimed to examine the drug survival...